CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.08
−3.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 116.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 50.57x
- Price / sales
- 3.10x
- Price / cash flow
- -2.33x
Enterprise value
- Enterprise value
- $108.2M
- EV / sales
- 2.87x
- EV / EBITDA
- -1.13x
- EV / EBIT
- -1.10x
- Market cap
- $116.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026